Innospera Pharma

Biotechnology Research • Montreal, Quebec, Canada • 1-10 Employees

Company overview

Headquarters	Montreal, Quebec, Canada
Website	innospera.com
NAICS	541714
Employees	1-10
Socials

Key Contacts at Innospera Pharma

Pierre Laurin

Founder & Executive Chairman

François Ravenelle

President And Chief Executive Officer

Innospera Pharma Email Formats

Innospera Pharma uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@innospera.com), used 60% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@innospera.com	60%
{first name}{last name}	johndoe@innospera.com	40%

About Innospera Pharma

Innospera is a privately-owned biotech company near clinical stage, developing small molecule modulators of 7-transmembrane receptors involved in a broad range of chronic and fibrotic conditions. The company’s lead drug candidates target key G-protein coupled receptors (GPCR) involved in fibroaging and inflammaging, including idiopathic pulmonary fibrosis (IPF), a condition with dire short-term prognosis. Innospera also develops multiple other modulators with promising potency in other medical conditions with pressing unmet needs. For more information, visit innospera.com

Innospera Pharma revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,500,000
Total funding	No funding